Amicus Therapeutics【FOLD】株式ニュース

名称	銘柄コード	市場	種別
Amicus Therapeutics Inc	FOLD	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.505	-4.74%	10.14	13:00:01

始値	安値	高値	終値	前日終値
10.53	10.13	10.57	10.14	10.645

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/08	08:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	08:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	08:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	08:49	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	08:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	08:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	08:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	08:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	05:38	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/6/08	05:06	EDGAR2	Form 8-K - Current report
2024/6/06	05:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/05	20:00	GLOBE	Amicus Therapeutics to Present at the Goldman Sachs 45th..
2024/5/10	05:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/09	20:00	EDGAR2	Form 8-K - Current report
2024/5/09	20:00	GLOBE	Amicus Therapeutics Announces First Quarter 2024 Financial..
2024/5/08	20:00	GLOBE	Amicus Therapeutics to Present at the Bank of America 2024..
2024/5/01	20:00	GLOBE	Amicus Therapeutics to Announce First Quarter 2024 Financial..
2024/3/20	20:00	GLOBE	Amicus Therapeutics Issues 2024 Environmental, Social, and..
2024/3/12	06:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/07	07:22	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	07:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	07:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/06	06:30	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/05	07:35	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/02	06:39	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/02	06:33	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/01	21:00	GLOBE	Amicus Therapeutics to Present at Upcoming Investor..
2024/2/28	21:02	EDGAR2	Form 8-K - Current report
2024/2/28	21:00	GLOBE	Amicus Therapeutics Announces Full-Year 2023 Financial..
2024/2/21	07:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/21	07:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/21	07:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/16	06:22	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/16	06:19	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/16	06:19	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/15	21:00	GLOBE	Amicus Therapeutics to Announce Full Year 2023 Financial..
2024/2/15	06:38	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/15	06:26	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/14	23:22	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/09	06:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/08	21:00	GLOBE	Amicus Therapeutics Receives the 2024 New Treatment Award..
2024/2/07	06:15	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/06	09:22	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/06	09:22	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/02	06:45	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/02	06:44	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/01	21:00	GLOBE	Amicus Therapeutics Announces Presentations and Posters at..
2024/1/27	01:49	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/25	07:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/23	06:18	EDGAR2	Form 144 - Report of proposed sale of securities